NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 4 filers reported holding NOVAVAX INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $315,000 | -70.0% | 571,000 | 0.0% | 0.01% | -71.1% |
| Q4 2018 | $1,051,000 | -2.1% | 571,000 | 0.0% | 0.04% | +15.4% |
| Q3 2018 | $1,073,000 | +40.3% | 571,000 | 0.0% | 0.04% | +34.5% |
| Q2 2018 | $765,000 | -36.2% | 571,000 | 0.0% | 0.03% | -38.3% |
| Q1 2018 | $1,199,000 | +69.4% | 571,000 | 0.0% | 0.05% | +74.1% |
| Q4 2017 | $708,000 | +8.8% | 571,000 | 0.0% | 0.03% | +17.4% |
| Q3 2017 | $651,000 | -0.9% | 571,000 | 0.0% | 0.02% | -4.2% |
| Q2 2017 | $657,000 | -10.1% | 571,000 | 0.0% | 0.02% | -14.3% |
| Q1 2017 | $731,000 | +1.7% | 571,000 | 0.0% | 0.03% | -9.7% |
| Q4 2016 | $719,000 | -39.5% | 571,000 | 0.0% | 0.03% | -32.6% |
| Q3 2016 | $1,188,000 | -54.4% | 571,000 | +59.5% | 0.05% | -56.6% |
| Q2 2016 | $2,603,000 | +40.9% | 358,000 | 0.0% | 0.11% | +34.2% |
| Q1 2016 | $1,847,000 | -38.5% | 358,000 | 0.0% | 0.08% | -27.5% |
| Q4 2015 | $3,004,000 | – | 358,000 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parametrica Management Ltd | 61,882 | $438,000 | 2.76% |
| BB BIOTECH AG | 8,330,000 | $58,893,000 | 1.87% |
| Cormorant Asset Management, LP | 1,600,000 | $11,312,000 | 1.81% |
| HARVEY CAPITAL MANAGEMENT INC | 623,950 | $4,411,000 | 1.76% |
| WILLIAM HARRIS INVESTORS INC | 488,666 | $3,455,000 | 0.98% |
| Eventide Asset Management | 2,097,500 | $14,829,000 | 0.86% |
| AWM Investment Company, Inc. | 400,000 | $2,828,000 | 0.55% |
| NORTHPOINTE CAPITAL LLC | 507,344 | $3,587,000 | 0.47% |
| Rock Springs Capital Management LP | 715,000 | $5,055,000 | 0.41% |
| Opus Point Partners Management, LLC | 100,000 | $707,000 | 0.39% |